Hayder Saeed, Associate Vice President at Tampa General Hospital, shared on LinkedIn:
“Grateful. That’s the word that keeps coming to mind as I move on from Bristol Myers Squibb.
Serving as the first Lymphoma Medical Engagement Lead has been one of the most rewarding chapters of my career, and what I’ll carry forward most is the people. Your unwavering commitment to patients inspired me every day.
A special thank you to Mecide Gharibo for your support, to all my BMS colleagues, and to the lymphoma colleagues I’ve had the privilege of collaborating with over the past couple of years.
Thank you for your partnership, your camaraderie, and your friendship.
You won’t be rid of me entirely.
See you at ASH!”
Hayder Saeed’s contribution to hematologic oncology
Hayder Saeed is a hematologist and medical oncologist at Moffitt Cancer Center, where he focuses on the treatment of blood cancers, particularly Hodgkin and non-Hodgkin lymphomas.
His research contributes to improving the understanding and management of hematologic malignancies through
- early-phase clinical trials
- novel chemotherapy combinations
- population-based studies examining disease characteristics and patient outcomes.
His published work also addresses treatment-resistant lymphomas, T-cell malignancies, and complications associated with cancer immunotherapy. In addition, his research has explored factors influencing survival after hematopoietic stem cell transplantation, supporting efforts to refine risk assessment and improve outcomes for patients with complex blood cancers.
You may also be interested in:
Harvey Pekar: Lymphoma, Art, and Our Cancer Year